Literature DB >> 15390359

Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease.

Julie A Panepinto1, David C Brousseau, Cheryl A Hillery, J Paul Scott.   

Abstract

OBJECTIVE: As a measure of morbidity of vaso-occlusive crises (VOC) in sickle cell disease, we used a national hospital discharge database, the Kids' Inpatient Database (KID), to determine the number of hospitalizations and hospital length of stay (LOS) by age. PROCEDURE: Nationally weighted hospital discharges for VOC in children with sickle cell disease were analyzed using data from 2,500 hospitals in the Healthcare Cost and Utilization Project (HCUP) KID. Number of discharges and hospital LOS by age group were analyzed. Multiple linear regression was performed to analyze the effect of age on hospital LOS.
RESULTS: There were 20,271 hospital discharges for children with sickle cell disease and VOC. Mean age (SD) at time of admission was 10.6 (5.38) years with 49% being males. The overall average LOS was 4.4 days. There were differences in the number of hospital discharges by age group (P < 0.001). In addition, there was a difference in LOS by age group (P < 0.0001). After controlling for potential confounders, older age was associated with a longer LOS (P < 0.0001).
CONCLUSIONS: Older children with sickle cell disease and VOC have increased hospitalizations and longer LOS. This age effect should be considered when measuring the effect of an intervention on hospital utilization in these children.

Entities:  

Mesh:

Year:  2005        PMID: 15390359     DOI: 10.1002/pbc.20180

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  47 in total

1.  Socioeconomic status and length of hospital stay in children with vaso-occlusive crises of sickle cell disease.

Authors:  Angela M Ellison; Howard Bauchner
Journal:  J Natl Med Assoc       Date:  2007-03       Impact factor: 1.798

2.  Sickle-cell disease in California: a population-based description of emergency department utilization.

Authors:  Julie A Wolfson; Sheree M Schrager; Thomas D Coates; Michele D Kipke
Journal:  Pediatr Blood Cancer       Date:  2010-11-24       Impact factor: 3.167

3.  Thirty-day readmission rates following hospitalization for pediatric sickle cell crisis at freestanding children's hospitals: risk factors and hospital variation.

Authors:  Amy Sobota; Dionne A Graham; Ellis J Neufeld; Matthew M Heeney
Journal:  Pediatr Blood Cancer       Date:  2011-06-14       Impact factor: 3.167

4.  Association between Hospital Volume and Within-Hospital Intensive Care Unit Transfer for Sickle Cell Disease in Children's Hospitals.

Authors:  Jean L Raphael; Troy Richardson; Matt Hall; Suzette O Oyeku; David G Bundy; Ram V Kalpatthi; Samir S Shah; Angela M Ellison
Journal:  J Pediatr       Date:  2015-10-23       Impact factor: 4.406

5.  Association between clinical outcomes and metformin use in adults with sickle cell disease and diabetes mellitus.

Authors:  Sherif M Badawy; Amanda B Payne
Journal:  Blood Adv       Date:  2019-11-12

6.  Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial.

Authors:  Oluwakemi Badaki-Makun; J Paul Scott; Julie A Panepinto; T Charles Casper; Cheryl A Hillery; J Michael Dean; David C Brousseau
Journal:  Pediatr Blood Cancer       Date:  2014-01-17       Impact factor: 3.167

7.  Juvenile fibromyalgia in an adolescent patient with sickle cell disease presenting with chronic pain.

Authors:  Stalin Ramprakash; Daniel Fishman
Journal:  BMJ Case Rep       Date:  2015-10-01

8.  Concentration of hospital care for acute sickle cell disease-related visits.

Authors:  J A Panepinto; P L Owens; A L Mosso; C A Steiner; D C Brousseau
Journal:  Pediatr Blood Cancer       Date:  2011-12-16       Impact factor: 3.167

9.  Pharmacokinetics and analgesic effects of methadone in children and adults with sickle cell disease.

Authors:  Jennifer Horst; Melissa Frei-Jones; Elena Deych; William Shannon; Evan D Kharasch
Journal:  Pediatr Blood Cancer       Date:  2016-08-30       Impact factor: 3.167

10.  Postdischarge pain, functional limitations and impact on caregivers of children with sickle cell disease treated for painful events.

Authors:  Amanda M Brandow; David C Brousseau; Julie A Panepinto
Journal:  Br J Haematol       Date:  2008-12-01       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.